EDGAR Filing Documents for 0001193125-12-421089

Form 8-K - Current report:

SEC Accession No. 0001193125-12-421089

Filing Date

2012-10-11

Accepted

2012-10-11 17:02:01

Documents

Period of Report

2012-10-04

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d423557d8k.htm	8-K	34824
2	UNDERWRITING AGREEMENT	d423557dex11.htm	EX-1.1	182685
3	ARTICLES OF AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION	d423557dex31.htm	EX-3.1	86085
4	FORM OF SERIES 17 PREFERRED STOCK CERTIFICATE	d423557dex41.htm	EX-4.1	8351
5	OPINION OF KARR TUTTLE CAMPBELL	d423557dex51.htm	EX-5.1	10511
6	PRESS RELEASE, DATED OCTOBER 4, 2012	d423557dex991.htm	EX-99.1	11013
7	PRESS RELEASE, DATED OCTOBER 5, 2012	d423557dex992.htm	EX-99.2	11345
8	GRAPHIC	g423557image-1.jpg	GRAPHIC	3404
9	GRAPHIC	g423557image-2.jpg	GRAPHIC	4725
	Complete submission text file	0001193125-12-421089.txt		357648

Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121

Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100

CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)